Singh Shawn 4
4 · VistaGen Therapeutics, Inc. · Filed Apr 27, 2021
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-04-23−5,000→ 0 totalExercise: $1.50From: 2018-08-29Exp: 2021-04-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2021-04-23$1.50/sh+5,000$7,500→ 40,375 total
Holdings
- 26,234(indirect: By Trust)
Common Stock